Literature DB >> 25363327

Reply: To PMID 25098971.

Jeremie Guedj1,2, Laetitia Canini3,4, Scott Cotler3, Harel Dahari3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25363327      PMCID： PMC4739520          DOI： 10.1002/hep.27594

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals.

Authors:  John M Murray; Anthony D Kelleher; David A Cooper
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life.

Authors:  Jeremie Guedj; Harel Dahari; Libin Rong; Natasha D Sansone; Richard E Nettles; Scott J Cotler; Thomas J Layden; Susan L Uprichard; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

3.  Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling.

Authors:  Jeremie Guedj; Yaron Rotman; Scott J Cotler; Christopher Koh; Peter Schmid; Jeff Albrecht; Vanessa Haynes-Williams; T Jake Liang; Jay H Hoofnagle; Theo Heller; Harel Dahari
Journal:  Hepatology       Date:  2014-10-27       Impact factor: 17.425

4.  Hepatitis delta virus inhibits alpha interferon signaling.

Authors:  Paolo Pugnale; Valerio Pazienza; Kévin Guilloux; Francesco Negro
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

5.  In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

Authors:  Bruno B Bordier; Junko Ohkanda; Ping Liu; So-Young Lee; F H Salazar; Patricia L Marion; Kazuo Ohashi; Leonard Meuse; Mark A Kay; John L Casey; Said M Sebti; Andrew D Hamilton; Jeffrey S Glenn
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.